Previous 10 | Next 10 |
PENNINGTON, N.J. and SAN DIEGO , May 27, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced Notices of Allowance for three new patent applications coverin...
PENNINGTON, N.J. and SAN DIEGO , May 21, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (the "Company" or "OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that it will present new pre-clinical data demonstrating th...
PENNINGTON, N.J. and SAN DIEGO , May 14, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, announced today that its partnering with the Melanoma Research Foundation (MRF) to raise awareness ab...
Investigators at Providence Cancer Institute are on board with a Phase 1 clinical trial evaluating OncoSec Medical's (NASDAQ: ONCS ) CORVax12 COVID-19 vaccine candidate. They hope for FDA sign-off by month-end. More news on: OncoSec Medical Incorporated, Healthcare stocks news, Stocks on...
PENNINGTON, N.J. and SAN DIEGO , May 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (Nasdaq:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the European Medicines Agency (EMA) issued an advanced therapy...
SAN DIEGO and PENNINGTON, N.J. , May 6, 2020 /PRNewswire/ -- Oncosec Medical Incorporated (the "Company" or "Oncosec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced published data in Clinical Cancer Research , linked here ,...
SAN DIEGO and PENNINGTON, N.J. , April 21, 2020 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS) , a company developing late-stage intratumoral cancer immunotherapies, today announced pre-clinical data from a feasibility study of its visceral lesion applicator (V...
SAN DIEGO and PENNINGTON, N.J. , April 20, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (Nasdaq:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the appointment of Herbert Kim Lyerly , M.D., George Barth ...
OncoSec Medical (NASDAQ: ONCS ) -13% . More news on: OncoSec Medical Incorporated, Chimera Investment Corporation, Co-Diagnostics, Inc., Stocks on the move, , Read more ...
Gainers: Immunomedics (NASDAQ: IMMU ) +90% . More news on: Immunomedics, Inc., Akers Biosciences, Inc., Exantas Capital Corp., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
OncoSec Medical Incorporated Company Name:
ONCS Stock Symbol:
NASDAQ Market:
2023-06-25 06:00:00 ET 3 Tips for Investing in Penny Stocks in a Highly Volatile Market In the thrilling world of finance, penny stocks hold a unique place, providing investors with an affordable entry point and the potential for significant returns. As securities trading under $5 p...
2023-06-24 06:00:00 ET 3 Ways That Global Events Affect the Price of Penny Stocks The ever-changing global economic landscape inevitably impacts the financial markets, and penny stocks , defined as securities trading below $5 per share, are no exception. Particularly in 2023, these ...